The Gulf conflict has disrupted global supply chains, pushed...
REITs have changed the way commercial real estate is owned a...
What really powers the cloud? Behind every Google search, A...
What really powers the cloud? Behind every Google search, A...
Luxury real estate is one of the most talked-about segments ...
Sandur Manganese and Iron Ores Ltd has announced that its subsidiary, Royal Sandur, has entered the medical devices and consumables sector by taking a long-term land lease at the Andhra Pradesh MedTech Zone (AMTZ) in Visakhapatnam. The development marks the company's move into a new business segment beyond its existing operations. The announcement confirms the land lease and sector entry, but the available report does not specify the leased land area, lease duration, investment amount, proposed manufacturing facilities or project timeline.
Sandur Manganese and Iron Ores Ltd has entered the medical devices and consumables sector through its wholly owned subsidiary, Royal Sandur MedTech Private Limited, which has taken a long-term land lease at the Andhra Pradesh MedTech Zone (AMTZ) in Visakhapatnam to establish a manufacturing facility.
The lease agreement was executed on October 19, 2026, between Royal Sandur MedTech and Andhra Pradesh MedTech Zone Limited, a Government of Andhra Pradesh undertaking that operates the medical technology park. The leased land measures 6.2 acres, or approximately 25,090 square metres, and has a tenure of 33 years. The agreement also provides an option to convert the leasehold rights into freehold ownership after 10 years from the commencement of business.
The leased site has access to infrastructure including roads, electricity, water and effluent management systems provided by AMTZ. Royal Sandur MedTech has also taken office space at the World Trade Center within AMTZ to support project development.
The entry into medical devices and consumables forms part of Sandur Manganese's plans to expand beyond its established mining and metals businesses. The company has traditionally focused on manganese and iron ore mining, while its wider operations also include steel and related businesses. Its diversification plans are intended to develop additional business areas alongside its existing operations.
Sandur Manganese Managing Director Bahirji A. Ghorpade said the company wanted to build new sources of growth alongside its core businesses. He noted that AMTZ's shared manufacturing and scientific facilities could help a new entrant develop capabilities without having to establish every facility independently.
The company has not yet disclosed the planned capital expenditure, the specific medical devices or consumables it intends to manufacture, or the expected timeline for setting up and starting operations at the facility. Further details on the project are expected to be announced in due course.
The AMTZ land lease gives Sandur Manganese a site for its proposed entry into medical technology manufacturing, while the 33-year tenure provides a long-term arrangement for the planned facility. The next developments to watch are the company's investment plans, the products it intends to manufacture and the schedule for commissioning the unit. These details will help clarify the scale of its expansion into the medical devices and consumables business. For now, the announcement confirms the land lease and the company's entry into the sector, rather than a completed or operational manufacturing facility.
Source Reuters
17th Nov, 2026
16th Nov, 2026
16th Nov, 2026
15th Nov, 2026
14th Nov, 2026
14th Nov, 2026